Rongshou Zheng1, Hongmei Zeng1, Siwei Zhang1, Yaguang Fan2, Youlin Qiao3, Qinghua Zhou2, Wanqing Chen1. 1. National Cancer Center of China Beijing, China. 2. Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin, China. 3. Department of Cancer Epidemiology, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing, China.
Abstract
BACKGROUND: The National Central Cancer Registry of China (NCCR) is responsible for cancer surveillance. Local cancer registries in each province submit data for annual publication. The incidence and mortality of lung cancer in China in 2010 by age, gender, and area is reported in this article. METHODS: In 2013, 145 of 219 population-based cancer registries' 2010 data were selected after quality evaluation. Classification included Western, Middle, and Eastern areas, and the crude incidence and mortality rates of lung cancer were calculated by age, gender, and urban and rural. Age-standardized rates were determined by China and World standard population data. The 6th National Population Census data of China was used, combined with the registries' data to estimate the lung cancer burden in China in 2010. RESULTS: Lung cancer had the highest incidence and mortality in China for men and women. It was estimated that 605 946 lung cancer cases were diagnosed in China in 2010, with a crude incidence rate of 46.08/100 000, and 486 555 patients died from lung cancer, with a crude mortality rate of 37.00/100 000. Age-standardized rates for incidence were 35.23/100 000 and 35.04/100 000, respectively. Incidence and mortality rates for lung cancer were higher in men and urban areas than those in women and rural areas, reaching a peak for subjects of 80-84 years old. CONCLUSION: Lung cancer has the highest incidence and mortality of all cancers in China, especially for males in urban areas. Our findings justify the need to plan and develop effective interventions, such as air pollution control and smoking deterrents, to control and prevent the spread of lung cancer in China.
BACKGROUND: The National Central Cancer Registry of China (NCCR) is responsible for cancer surveillance. Local cancer registries in each province submit data for annual publication. The incidence and mortality of lung cancer in China in 2010 by age, gender, and area is reported in this article. METHODS: In 2013, 145 of 219 population-based cancer registries' 2010 data were selected after quality evaluation. Classification included Western, Middle, and Eastern areas, and the crude incidence and mortality rates of lung cancer were calculated by age, gender, and urban and rural. Age-standardized rates were determined by China and World standard population data. The 6th National Population Census data of China was used, combined with the registries' data to estimate the lung cancer burden in China in 2010. RESULTS:Lung cancer had the highest incidence and mortality in China for men and women. It was estimated that 605 946 lung cancer cases were diagnosed in China in 2010, with a crude incidence rate of 46.08/100 000, and 486 555 patients died from lung cancer, with a crude mortality rate of 37.00/100 000. Age-standardized rates for incidence were 35.23/100 000 and 35.04/100 000, respectively. Incidence and mortality rates for lung cancer were higher in men and urban areas than those in women and rural areas, reaching a peak for subjects of 80-84 years old. CONCLUSION:Lung cancer has the highest incidence and mortality of all cancers in China, especially for males in urban areas. Our findings justify the need to plan and develop effective interventions, such as air pollution control and smoking deterrents, to control and prevent the spread of lung cancer in China.
Entities:
Keywords:
Cancer epidemiology; Chinese data; lung cancer
Authors: Melinda C Aldrich; Eric L Grogan; Heather M Munro; Lisa B Signorello; William J Blot Journal: J Thorac Oncol Date: 2013-10 Impact factor: 15.609
Authors: T Frauenfelder; M A Puhan; R Lazor; C von Garnier; J Bremerich; T Niemann; A Christe; X Montet; O Gautschi; W Weder; M Kohler Journal: Respiration Date: 2014-01-16 Impact factor: 3.580
Authors: Yutian Lai; Cheng Shen; Xin Wang; Heng Du; Dali Chen; Long Tian; Xudong Zhou; Guowei Che Journal: Thorac Cancer Date: 2015-07-24 Impact factor: 3.500